DR. JAYEETA GIRI

Academic Background

B.Sc: Chemistry, University of Calcutta, Kolkata, 2007

MSc: Biochemistry, University of Calcutta, Kolkata, 2009

Ph.D: Biochemistry, University of Calcutta, Kolkata, 2016

Professional Experience

• Assistant Professor & India Alliance DBT Wellcome Trust Fellow: NMIMS Deemed to be University, April-2026 -Present
• India Alliance DBT Wellcome Trust Fellow at ICMR-NIRRCH: 1^st September 2023 to 1^st April 2026
• Post doctoral Fellow at Carbon Cancer Centre, University of Wisconsin-Madison, USA: 6^th March 2017 – 31^st April, 2020

Research Interest

Primary focus of our lab is to understand the role of adult stem cells in regulation of tissue homeostasis, and how stem cells’ dysfunction leads to pathological disorders. Present working model is Women with recurrent implantation failure. We are also going to study endometrial cancer, endometriosis, endometrisis etc.

• Characterization of stem cells: Establish stem cells culture from different tissue sources of human and mice, characterize them on basis of adult stem cells markers & multilineage differentiation capacity.
• Understand stem cells and tissue cross-talk: Develop organoid from healthy or pathological tissue. Identify how MSCs derived exosome interact with the organoid and modify their physiology.
• Drug Development: Utilize Exosome as drug delivery vehicle or nano carrier against women reproductive diseases.

Funding:

India Alliance DBT Wellcome Trust

Recent Publications:

Giri J*, Galipeau J, Modi D. Standardized Isolation and Cytokine Priming of Murine Bone Marrow-Derived Mesenchymal Stem Cells (BMSCs) for Enhanced Immunomodulation. Journal of Visualized Experiments (JoVE), (2025); (*Invited corresponding author). Impact factor: 1.2

Giri J*. Optimizing Mesenchymal Stromal Cells Delivery: Present Status and New Frontiers in Regenerative Medicine. Journal of Stem Cell Reports, (2024). (*invited corresponding author). Impact factor: 2.3

Giri J*, Modi D*. Endometrial and Placental stem cells in successful and pathological pregnancies. Journal of Assisted Reproduction and Genetics, (2023); (*corresponding author). Impact factor: 3.6

Giri J*, Moll G. MSC in Space: Mesenchymal Stromal Cell Therapeutics as Potential Enabling Technology for Long-Distance Manned Space Travel. Current Stem cell Reports, (2022); (*invited corresponding author). Impact factor: 2.3

Giri J, Basu M, … Ukil A. Translationally Controlled Tumor Protein–Mediated Stabilization of Host Antiapoptotic Protein MCL-1 Is Critical for Establishment of Infection by Intramacrophage Parasite Leishmaniadonovani. Journal of Immunology, (2022). Impact factor: 5.43

Giri J and Galipeau J. Mesenchymal Stromal Cell Therapeutic Potency is Dependent Upon Viability, Route of Delivery, and Immune Match. Blood advances, (2020). Impact factor: 7.6

Giri J, Das R, Nylen E, Chinnadurai R and Galipeau J. Mesenchymal Stromal Cells Derived CCL2/CXCL12 Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury. Cell Reports, (2020). Impact factor: 8.1

Teaching

• Stem Cell Biology
• Immunology
• Biochemistry
• Molecular Biology
• Cell Biology

Awards/Honor

• India Alliance DBT Wellcome Trust Early Career Fellowship, DBT India
• NIH-funded Post-doctoral Fellowship, USA
• Senior Research Associateship under the Scientists' pool Scheme (CSIR-Pool Scientist), CSIR-India
• DBT-RA (2^nd position in interview), DBT, India
• Early-Stage Professional Award, International society of Cell & Gene Therapy, USA
• Qualified CSIR-NET & GATE.